Protalex, Inc. Employee Directory
Biotechnology ResearchNew Jersey, United States2-10 Employees
Protalex, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune and inflammatory diseases, including rheumatoid arthritis. Its lead candidate, PRTX-100, is based on a purified form of Staphylococcal Protein A derived from Staphylococcus aureus and is designed to interact with B-lymphocytes and macrophages to modulate immune pathways involved in inflammation. The company aims to address immune-mediated conditions at very low doses, with pre-clinical and early human studies indicating safety and tolerability across evaluated dose levels. Based in Florham Park, New Jersey, Protalex operates within the biotechnology research sector as it advances its immunomodulatory approach. The organization is a small- to midsize enterprise pursuing clinical development and potential translational applications for autoimmune diseases through its lead product and related research programs.